<DrugInformationSummary id="CDR0000689690"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Eribulin mesylate is a type of chemotherapy drug called an antimicrotubule agent. It is a laboratory-made version of a natural product called halichondrin B. It works by disrupting microtubules (cellular structures that help move chromosomes during mitosis). It blocks cell growth by stopping mitosis (cell division) and causes cells to die.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/eribulinmesylate">Eribulin Mesylate</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000257773">Eribulin Mesylate</TerminologyLink><GlossaryLink ref="CDR0000690373">eribulin mesylate</GlossaryLink><USBrandNames><USBrandName>Halaven</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>er-eh-BYOO-lin MEH-zih-layt</TermPronunciation><MediaLink ref="CDR0000727545" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000727546" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Eribulin Mesylate</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Eribulin mesylate
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that has <GlossaryTermRef href="CDR0000046283" dictionary="Cancer.gov" audience="Patient">metastasized</GlossaryTermRef> (spread to other parts of the body). It is used in patients who have already been treated with at least 2 types of chemotherapy for metastatic cancer, including an <GlossaryTermRef href="CDR0000044916" dictionary="Cancer.gov" audience="Patient">anthracycline</GlossaryTermRef> and a <GlossaryTermRef href="CDR0000046138" dictionary="Cancer.gov" audience="Patient">taxane</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046028" dictionary="Cancer.gov" audience="Patient">Liposarcoma</GlossaryTermRef></Strong> (a type of <GlossaryTermRef href="CDR0000046584" dictionary="Cancer.gov" audience="Patient">soft tissue sarcoma</GlossaryTermRef>) that cannot be removed by surgery or has metastasized. It is used in patients who have already been treated with anthracycline chemotherapy.</ListItem></ItemizedList>
 <Para id="_4">Eribulin mesylate is also being studied in the treatment of other types of cancer.</Para></Section><Section id="_About"><Title>More About Eribulin Mesylate</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/257773">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.4">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a611007.html">Eribulin Mesylate</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.5"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.6">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C26644">Find Clinical Trials for Eribulin Mesylate</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2010-12-10</DateFirstPublished><DateLastModified>2025-01-02</DateLastModified></DrugInformationSummary>
